Gemcitabine hydrochloride
Drug timelines are a Plus or Pro feature.
68 regulatory and trial events tracked for Gemcitabine hydrochloride, covering 2011-07-25 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]